Tvardi Therapeutics Inc. Com
13F holders, Q3 2025 (September 30)8holders +1
1new positions
0sold out
$38.92avg. 13F price*
At the end of Q3 2025, 8 institutions reported holding Tvardi Therapeutics Inc. Com in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Duncan Williams Asset Management, LLC ($859K), LRI Investments, LLC ($3K) and Cornerstone Planning Group LLC ($330).
- Company
- Tvardi Therapeutics Inc. Com
- CUSIP
- 140755208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $86 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 236 shares bought, net +236 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Duncan Williams Asset Management, LLC | 0.24% | Add +0.9% | 22,030 | $859K |
| LRI Investments, LLC | 0.00% | No change | 82 | $3K |
| Cornerstone Planning Group LLC | 0.00% | Add +3400.0% | 35 | $330 |
| Painted Porch Advisors LLC | 0.00% | No change | 6 | $234 |
| Creative Financial Designs Inc. | 0.00% | No change | 6 | $234 |
| Farther Finance Advisors, LLC | 0.00% | No change | 3 | $117 |
| Sound Income Strategies, LLC | 0.00% | New | 2 | $86 |
| Front Row Advisors LLC | 0.00% | No change | 1 | $39 |
"% of holder's portfolio" is TVARDI THERAPEUTICS INC COM's weight in each manager's 13F, not the share of Tvardi Therapeutics Inc. Com the manager owns.